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Abstract
Background: The suspected blood indicator (SBI) function in the RAPID 
Reader v8.3 program was designed to quickly identify the presence of 
blood in video capsule endoscopy. While previous retrospective studies 
have shown that the SBI function was accurate in detecting the presence of 
active bleeding in the small bowel, its specificity and sensitivity were poor.
Methods: An initial retrospective review (phase 1) compared 115 pa-
tients with active gastrointestinal bleeding seen on video capsule en-
doscopy (VCE) to 115 patients with no active bleeding seen on VCE 
to produce a highly accurate algorithm. A prospective study (phase 
2) was then performed by applying the algorithm to 100 consecu-
tive patients who received VCE for the following indications: obscure 
bleeding, iron deficiency anemia, melena, and hematochezia.
Results: The initial retrospective review found that eight contiguous 
SBI markers had a specificity of 100% in identifying active gastroin-
testinal bleeding regardless of the total number of SBI markers, while 
two or more contiguous SBI markers had a sensitivity of 96.5%. Us-
ing a cutoff of eight contiguous SBI markers, the prospective arm 
found that there was a 100% sensitivity and specificity in detecting 
active gastrointestinal bleeding (P < 0.001).
Conclusions: The SBI function can greatly facilitate the identifica-
tion of active gastrointestinal bleeding on VCE by using eight con-
tiguous SBI markers as a cutoff for active bleeding.
Keywords: Video capsule endoscopy; Gastrointestinal bleeding; 
Small bowel endoscopy; Obscure bleeding; Small bowel bleeding
Introduction
Video capsule endoscopy (VCE) has become a primary tool in 
evaluating obscure gastrointestinal (GI) bleeding. The overall 
yield of VCE in identifying causes of obscure GI bleeding has 
been reported to range from 30-92% and is significantly higher 
than detection via push enteroscopy or other modalities [1, 2]. 
Lesions detected by VCE typically include small bowel an-
gioectasias, ulcers, inflammation and tumors and may detect 
abnormalities in other organs such as esophagitis/gastritis [3]. 
As might be expected, the diagnostic yield is optimized if the 
capsule is deployed as close as possible to a bleeding episode 
[2-4].
A major drawback in VCE resides in the time-consuming 
and meticulous process of analyzing VCE videos. Typically 
involving over 50,000 images for the entire video, VCE re-
quires not only a significant time commitment, but also an 
experienced reader adept at identifying abnormalities. The 
Given Imaging Rapid Reader program (RAPID Reader v.8.3, 
Given Imaging, Yoqneam, Israel, 2015) includes a software 
function known as “suspected blood indicator” (SBI) which 
is programmed to detect red-colored clusters of pixels in im-
ages and correspondingly sets markers, which appear as red 
bars, thus notifying the reader of what appears to be blood. A 
previous version of SBI had a low sensitivity in detecting ac-
tive bleeding, and was upgraded in the current RAPID Reader 
program [5].
An accurate SBI function could greatly expedite VCE 
reading in detecting GI bleeding. This study evaluates the ac-
curacy of SBI in detecting bleeding throughout the entire GI 
tract, while attempting to determine the number of contiguous 
SBI bars needed to accurately and consistently identify lumi-
nal blood related to active GI bleeding.
Materials and Methods
Phase 1 consisted of a single center retrospective review of 
consecutive patients who were found to have active bleeding 
on VCE reports during a period from January, 2015 to June, 
2015. Indications for the VCE included obscure GI bleed-
ing, iron deficiency anemia, melena, and hematochezia. A 
control group consisting of the same number of individuals 
from the same time period was also analyzed. This control 
group consisted of patients who received VCE for indica-
tions such as abdominal pain or concern for inflammatory 
bowel disease or celiac disease and were found to not have 
any active GI bleeding. The Institutional Review Board ap-
proved the study.
All patients received VCE under standard procedure as 
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detailed by Iddan et al [6]. Preparation was limited to nil per 
os for 12 h. Digital videos of the VCE imaging had been read 
and analyzed using the RAPID Reader v8.3 software by one 
of two experienced clinicians who have reviewed over 2,000 
VCE cases each. Active bleeding was defined as the finding of 
blood by one of the experienced clinicians as noted on the final 
report, which included the location of bleeding and if possible, 
the etiology of the bleeding. No active bleeding was defined as 
the absence of blood, which was also noted on the final report 
by one of two experienced clinicians. Two separate investiga-
tors (SH and JF) then analyzed the videos utilizing the SBI 
function, identifying SBI markers and their correlation with 
images displaying active bleeding (Fig. 1). SBI markers were 
then recorded to include true positive SBI markers as well as 
false positive SBI markers. False positive SBI markers were 
defined as red bars that were triggered by the SBI function, but 
were found on review to not have any blood in the frame. Us-
ing this data, a cutoff number for SBI markers with high sen-
sitivity and specificity in identifying active GI bleeding was 
then calculated.
Upon completion of this retrospective review, the cutoff 
for SBI markers derived from phase 1 was then applied in a 
prospective validation (phase 2). Consecutive patients were 
enrolled from September, 2015 to December, 2015 under in-
clusion criteria consisting of the following indications: VCE 
for obscure GI bleeding, iron deficiency anemia, melena, or 
hematochezia. The VCE images were reviewed by the same 
two experienced investigators as described above, and SBI 
markers were then reviewed by the same two separate inves-
tigators as described above. SBI markers were again recorded 
to include true positive SBI markers as well as false positive 
SBI markers.
Statistical analysis
Student’s t-test and Fisher’s exact test were used to compare 
continuous and categorical variables, respectively. Sensitivity, 
specificity, positive predictive value and negative predictive 
value were calculated utilizing contingency tables. A P value 
less than 0.05 was considered to be statistically significant. All 
analysis was performed using STATA (StataCorp, College Sta-
tion, Texas).
Results
Phase 1
The initial retrospective review (phase 1) consisted of video 
capsule data from 230 patients at our institution, a tertiary aca-
demic medical center. One half (n = 115) had active GI bleed-
ing, while the other half was used as a control group. The SBI 
function was able to detect 100% of the 115 active GI bleed-
ing cases documented on VCE. The most common finding on 
VCE in the GI bleeding group was angioectasia, which was 
found in 45 patients (39.1%) in the bleeding group compared 
to seven patients (6.09%) in the non-bleeding group. Other 
VCE findings are seen in Figure 2. VCE alone was able to 
detect the cause of bleeding in 53.7% in the active GI bleeding 
group, and the use of further modalities produced an overall 
determination rate of 79.1% for etiology of bleeding. Compar-
ing the active bleeding group and the control group, the active 
bleeding group was significantly older (68.1 vs. 57 years, P < 
0.001) and had significantly more contiguous SBI bars than the 
control group (21.1 vs. 1.2, P < 0.001) (Table 1). Patients in the 
active bleeding group also had a higher mean number of SBI 
markers than the control group, with a mean number of 21.2 
SBI markers in the GI bleeding group and 1.2 SBI markers in 
the control group (P < 0.01). The distribution of contiguous 
SBI bars was also found to be significantly different between 
the two groups (P < 0.001) as seen in Figure 3.
A ROC curve (Fig. 4) and contingency table (Table 2) de-
termined that eight contiguous SBI bars or more had 100% 
specificity in identifying a GI bleed with 45.2% of the active 
GI bleeding cases having less than eight contiguous bars. Us-
ing eight continuous bars, sensitivity was 53%, positive predic-
tive value was 100% and negative predictive value was 68.1%. 
On the other hand, it was determined that two contiguous SBI 
bars or more had 96.5% sensitivity and 66.1% specificity in 
identifying a GI bleed.
Phase 2
Phase 2 found a 100% sensitivity and specificity in identifying 
active GI bleeding using the formula of eight contiguous SBI 
markers derived from phase 1. This prospective arm detected 
18 cases (18%) of active GI bleeding. In cases of active GI 
bleeding, the mean number of total bars, false positive bars, 
and contiguous bars was 37, 4.5 and 32.5, respectively (Table 
3). The active bleeding group had a higher number of total SBI 
Figure 1. Example of active bleeding with suspected blood indicator 
markers (red bars).
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bars (37 vs. 4.9, P < 0.001) and contiguous bars (32.5 vs. 0.6, 
P < 0.001) than that of the non-bleeding group. The most com-
mon cause of bleeding found was angioectasia (38.9%) and 
other causes are displayed in Table 4.
Table 1.  Retrospective Comparison of Active Bleeding and Non-Bleeding Groups
Categories Active bleeding No active bleeding P value
Age 68.1 ± 14.3 57.0 ± 18.9 < 0 .001
Male gender 59 (51.3%) 56 (48.7%) 0.7
Total number of bars 21.2 ± 34.5 1.2 ± 2 < 0.001
False positive bars 4.5 ± 5.7 4.3 ± 6.5 0.8
Contiguous bars 21.1 ± 34.3 1.2 ± 1.9 < 0.001
Figure 2. Etiology of gastrointestinal bleeding in phase 1.
Figure 3. Distribution of contiguous bars.
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Discussion
This study evaluated the capability of the SBI function in the 
RAPID Reader v8.3 software to accurately predict active GI 
bleeding. The SBI function was successfully able to detect all 
active GI bleeds and it appears that a series of eight contiguous 
SBI bars allows for 100% sensitivity and specificity.
Previously, Stein et al utilized the Quickview function in 
the RAPID Reader software v6.0 in conjunction with the SBI 
function and found an overall sensitivity of 100% in detecting 
28 cases of active small bowel bleeding [7]. Tal et al utilized 
the SBI function alone and also found 100% sensitivity in de-
tecting 42 cases of active small bowel bleeding, with a mean 
of 46.6 SBI bars in major bleeding cases and a mean of 36 SBI 
bars in minor bleeding cases [8]. Using that data, they created 
an optimal cutoff value of SBI number < 51 to correspond to 
a “no bleeding” group with > 51 SBI bars corresponding to 
a “true bleeding” group. This enabled a sensitivity of 79.1% 
and a specificity of 90.4%. Our study expands on these stud-
ies by evaluating bleeding throughout the entire GI tract and 
taking into account the importance of contiguous SBI bars. As 
blood flows through the GI tract from a particular source, the 
blood would be expected to appear in a consecutive series of 
images, reflecting the progression of the video capsule which 
also travels through the GI tract. This reflects the importance 
of the contiguous number of SBI bars in detecting an active GI 
bleed and implies that there could be a number of contiguous 
bars which would correspond well to active bleeding. In this 
study, we identified eight contiguous bars as representing the 
ideal number to effectively rule in an active GI bleed, and we 
found a contiguous series much easier to identify and count, as 
opposed to counting over 50 individual bars as suggested by 
Tal et al [8].
In terms of the detection capabilities of VCE, Liao et 
al performed a large meta-analysis including 22,840 VCE 
procedures and found a bleeding detection rate of 61% [9]. 
Lepileur et al looked at VCE procedures done for the in-
dication of obscure GI bleeding and found that VCE was 
able to identify a cause of bleeding in 56% of the cases [3]. 
Our results were in line with these studies, as we were able 
to identify a source of bleeding in 53.7% of the retrospec-
tive cases and 68.8% in the prospective cases. The failure to 
detect bleeding more frequently reflects the timing of VCE 
Figure 4. ROC curve of SBI accuracy in phase 1 in detecting active 
gastrointestinal bleeding.
Table 2.  Contingency Table Demonstrating Use of Eight Contiguous SBI Markers as Cutoff for Active Gastrointestinal Bleeding
Bleeding No bleeding
Contiguous SBI Eight or more 61 0
Less than eight 54 115
Total 115 115
Sensitivity 53%
Specificity 100%
Positive predictive value 100%
Negative predictive value 68.1%
SBI: suspected blood indicator.
Table 3.  Comparison of Active Bleeding and Non-Bleeding Groups in Prospective Arm
Variables Active bleeding No active bleeding P value
Age 68.6 ± 15.7 63.7 ± 15.7 0.24
Female gender 12 (66.7%) 43 (52.4%) 0.27
Total number of bars 37 ± 31.4 4.9 ± 6.7 < 0.001
False positive bars 4.5 ± 4.2 4.2 ± 5.9 0.82
Contiguous bars 32.5 ± 31.7 0.6 ± 1.4 < 0.001
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and the intermittent nature of GI bleeding. With the use of 
further modalities such as double-balloon enteroscopy and 
spiral enteroscopy, the etiology was able to be elucidated in 
nearly 80% of both the retrospective and prospective cases 
in this study, which reflects the elusive nature of obscure GI 
bleeding.
The importance of this study stems from the possibil-
ity that VCE may be useful in the evaluation and triage of 
suspected GI bleeding, particularly in the emergency room 
(ER). Sung et al performed a randomized controlled trial 
evaluating the utility of VCE in patients presenting to the 
ER with suspected upper GI bleeding [10]. Patients receiv-
ing VCE were triaged based on real-time capsule results, 
with patients being discharged from the ER if there were no 
significant endoscopic findings. This feasibility study found 
that there was no difference in recurrent bleeding and 30-
day mortality between patients who received VCE and those 
who received standard care, while hospitalization rates were 
significantly lower in the VCE group. While further trials 
need to be conducted to validate the use of VCE in acute GI 
bleeding, their study highlighted the benefit of using VCE 
early in the workup of GI bleeding. The SBI function could 
then prove very useful in the quick and accurate detection of 
acute bleeding, and help direct appropriate therapy, poten-
tially improving patient outcomes, decreasing length of stay, 
and thereby reduce costs.
The presence of false positive bars presents the largest 
limitation of the SBI function. Slightly less than half of the 
active GI bleeding cases had false positive bars, and about 
25% of the control group had false positive bars as well. In 
examining the false positive bars, the majority appear to be 
due to bubbles in the GI lumen, which appear to reflect light 
that is identified by the software as being red in color. How-
ever, not all bubbles elicit a response in the SBI bar; it appears 
that only a specific orientation of the camera in relation to the 
bubble will reflect the red-colored light. Nevertheless, only 
rarely did these bubbles produce a continuous series of SBI 
bars, which can be accommodated for by utilizing a cutoff of 
eight contiguous bars. Conversely, false negatives may indi-
cate the failure of the SBI algorithm to detect colors that are 
slightly off-red. As blood can vary in color, the SBI is likely 
unable to detect all shades of red. Lastly, selection bias may 
have played a role in the increased sensitivity in phase 2 as 
there were only 18 cases of active bleeding in the prospective 
arm. Given that significant bleeding will span multiple frames 
and increase the likelihood of contiguous SBI markers, this 
likely reflects an inherent selection of patients in phase 2 with 
substantial bleeding.
Conclusions
In summary, the SBI function of the RAPID Reader v8.3 pro-
gram provides a quick, pragmatic approach to identifying ac-
tive GI bleeds. The quick identification of a contiguous series 
of eight red bars or more ensures detection of an active GI 
bleed, and the lack of a contiguous series of bars will help 
rule out GI bleeds. The presence of false positive bars, how-
ever, reinforces the importance of always reviewing the video 
capsule images, as bubbles are easy to identify. Since active 
GI bleeding always correlated with SBI markers, an appropri-
ate capsule reading strategy should include early review of the 
SBI markers.
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